NCT04787211 - A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 20, 2021

Primary Completion Date

December 2, 2021

Study Completion Date

December 2, 2021

Conditions

COVID-19

Interventions

DRUG

BRII-196 and BRII-198

BRII-196 and BRII-198 given by intravenous administration

DRUG

Placebo

Placebo given by intravenous administration

Trial Locations (6)

Beijing Ditan Hospital Capital Medical University, Beijing

Guangzhou Eighth Hospital, Guangzhou Medical University, Guangzhou

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

The Third People's Hospital of Shenzhen, Shenzhen

Subei People's Hospital of Jiangsu province, Yangzhou

Yunnan Provincial Infectious Disease Hospital, Kunming